Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin
Author:
Affiliation:
1. Institute of Health Economics, Edmonton, Alberta, Canada
2. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
3. Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://diabetesjournals.org/care/article-pdf/29/8/1990/594353/zdc00806001990.pdf
Reference4 articles.
1. Farooki A, Schneider SH: Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin (Letter). Diabetes Care 29:1989–1990, 2006
2. Bowker SL, Majumdar SR, Veugelers P, Johnson JA: Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29:254–258, 2006
3. van der Burg BB, Rutteman GR, Blankenstein MA, de Laat SW, van Zoelen EJ: Mitogenic stimulation of human breast cancer cells in a growth-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 134:101–108, 1988
4. Barker BE, Fanger H, Farnes P: Human mammary slices in organ culture. I. Methods of culture and preliminary observations on the effects of insulin. Exp Cell Res 35:437–448, 1964
Cited by 103 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chemopreventive and Biological Strategies in the Management of Oral Potentially Malignant and Malignant Disorders;Bioengineering;2024-01-09
2. The antiproliferative potential and mechanism of action of metformin in MCF-7 cells;Future Science OA;2023-06
3. Clinical potentials of metformin in cancer therapy;Journal of Diabetology;2023
4. Efficient one-pot synthesis of arylated pyrazole-fused pyran analogs: as leads to treating diabetes and Alzheimer's disease;Future Medicinal Chemistry;2022-11
5. Inhibition of Autophagy Promotes the Anti-Tumor Effect of Metformin in Oral Squamous Cell Carcinoma;Cancers;2022-08-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3